(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 5.18% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.99%.
Elanco Animal Health's revenue in 2026 is $4,893,000,000.On average, 17 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,575,661,499,531, with the lowest ELAN revenue forecast at $2,432,319,469,210, and the highest ELAN revenue forecast at $2,666,061,874,054. On average, 17 Wall Street analysts forecast ELAN's revenue for 2027 to be $2,711,012,336,524, with the lowest ELAN revenue forecast at $2,560,178,562,458, and the highest ELAN revenue forecast at $2,824,387,391,865.
In 2028, ELAN is forecast to generate $2,843,366,476,019 in revenue, with the lowest revenue forecast at $2,651,577,836,147 and the highest revenue forecast at $2,986,708,506,340.